课题基金 / 基金详情

Inhibitory effects on tumor invasion and metastasis induced by transfection of anti-sense E1AF,an ets-oncogene family transcription factor.

Inhibitory effects on tumor invasion and metastasis induced by transfection of anti-sense E1AF,an ets-oncogene family transcription factor.
ets-癌基因家族转录因子反义E1AF转染对肿瘤侵袭和转移的抑制作用。
批准号:
08672063
负责人:
SHINDOH Masanobu
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

SHINDOH Masanobu的其他基金

相似基金

相关文献

中文摘要
翻译
E1AF是一个新发现的人类Ets家族转录因子。我们已经报道,E1AF可以上调基质金属蛋白酶(MMPs)基因的转录,并赋予人癌细胞侵袭性表型。HSC3是一种口腔鳞状细胞癌来源的细胞系,其E1AF和基质金属蛋白酶-1、-9基因的高表达与口腔鳞癌的侵袭潜能有关。我们构建了E1AF反义表达载体,用该载体转染HSC3细胞,获得了表达E1AF反义RNA的HSC3AS细胞,HSC3AS的m、-3和-9呈下降趋势。此外,HSC3AS在体外三维RAFT培养和体内移植到裸鼠体内的侵袭能力较低。这些结果表明,反义E1AF通过下调基质金属蛋白酶基因来抑制肿瘤的侵袭。因此,E1AF被认为与癌细胞的恶性潜能高度相关,然而,在体内…中E1AF的表达与癌细胞恶性程度的关系却知之甚少更多的肿瘤。采用逆转录聚合酶链式反应、Southern杂交和原位杂交技术对27例口腔鳞状细胞癌标本进行检测,并与临床病理参数进行比较。27例患者中15例出现E1AF。17例侵袭性鳞癌S中有13例表达E1AFmRAN,而未表达E1AFmRAN的鳞癌S多呈膨胀性生长。在有淋巴结转移的病例中,E1AF阳性口腔鳞癌的患病率增加。这些结果表明,E1AF可能通过促进肿瘤细胞的侵袭潜能而参与肿瘤的发生。Waf1/Cip1&gt是细胞周期、终末分化和凋亡的关键调控蛋白之一。其启动子被野生型P53蛋白反式激活,并且不依赖于P53。我们证明了E1AF,一个ETS相关的转录因子,通过与两个先前发现的p53反应元件附近的ETS结合位点相互作用,激活了人的p21^;Waf1/Cip1>启动子。Northern印迹分析显示顺铂诱导的SiHA细胞p21^-lt;Waf1/Cip1>和E1AF表达上调。瞬时表达分析表明,E1AF可在SiHA细胞中激活p21^<Waf1/Cip1>启动子驱动的荧光素酶报告基因。在p53缺失的Saos2骨肉瘤细胞中,p21^<Waf1/Cip1>启动子活性也增加,但当Ets结合位点被删除时,活性显著降低。这些结果表明,E1AF正向调控p21^<Waf1/Cip1>启动子转录,以响应基因毒性胁迫。较少
英文摘要
E1AF is a newly identified human ets-family transcription factor. We have reported that E1AF can up-requlate transcription of matrix metalloproteinase (MMP) genes and confers invasive phenotype on human cancer cells. HSC3 is an oral squamous cell carcinoma-derived cell line, and it manifests high levels of E1AF,and MMP-1 and -9 gene expression that are associated with invasive potential. We reconstructed an E1AF antisense expression vector, transfected HSC3 cells with the vector and obtained HSC3AS cells which express E1AF antisense RNA.HSC3AS showed decreasing m, -3 and -9. moreover, HSC3AS showed lower invasive potential in in vitro three-dimensional raft culture and in vivo implantation into nude mice. These results imply that transfection of antisense E1AF inhibits tumor invasion by down-regulating MMP genes.Thus, E1AF is thought to be highly correlated with malignant potentials of cancer cells, however, little is known about E1AF expression and cancer cell malignancies in in vivo … More tumors. We examined 27 oral SCC speciment using RT-PCR,Southern blot hybtidization and in situ hybridization (ISH) and compared to the clinico-pathological parameters. Among the 27 patients, E1AF was detected in 15 cases. E1AF mRAN was detected in 13 of 17 invasive SCC_s, whereas the majority of SCC_s not expressing E1AF showed an expansive growth pattern. Increased prevalence of E1AF-positive oral SCC was observed in cases with nodal metastasis. These results indicate that E1AF may be involved in cancer cell malignancies through its ability to promote invasive potentialp21^<Waf1/Cip1> is one of the key requlatory proteins in cell cycle, terminal differentiation and apoptosis. its promoter was shown to be transactivated by the wild-type p53 protein as well as in a p53-independent manner. We demonstrate that E1AF,an ets-related transcription factor, activates the human p21^<Waf1/Cip1> promoter by interacting with the ets-binding sites located close to the two previously identified p53-responsive elements. Northern blot analysis revealed that p21^<Waf1/Cip1> and E1AF were correlatively uprequlated in response to cisplatin treatment in SiHa cells. Transient expression assays demonstrated that E1AF can activate the p21^<Waf1/Cip1> promoter-driven luciferase reporter gene in SiHa cells. The p21^<Waf1/Cip1> promoter activity was also increased in p53-null Saos2 osteosarcoma cells, but was markedly reduced when the etsbinding sites were deleted. These results indicate that E1AF positively requlates transcription from the p21^<Waf1/Cip1> promoter in response to genotoxic stresses. Less
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Shindoh, M., Higashino, F. et al.: "Correlated expression of matrix netalloproteinases and ets-family transcription on factor ELA-F in imvasive oral-squamous-ull-carinoma-usived cell lins." Am. J. Pathol.148 (3). 693-700 (1996)
Shindoh, M., Higashino, F. 等人:“在侵袭性口腔鳞状细胞癌使用的细胞中,基质金属蛋白酶的相关表达与 ELA-F 因子上的 ets 家族转录相关。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hida, K., Shindoh, M. et al.: "Expression of E1AF,an ets-Family Transcription Factor, is Correlated with the Invasive Phenotyne of Oral Squarnvao cell Carcinomas." European Journal of Cancer (Part B), Oral Oncol.33・6. 426-430 (1997)
Hida, K., Shindoh, M. 等人:“E1AF(一种 ets-家族转录因子)的表达与口腔 Squarnvao 细胞癌的侵袭性表型相关。”《欧洲癌症杂志》(B 部分),口腔肿瘤。 33・6。426-430(1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hida,K., Shindoh,M.et al.: "Antisenes E1AF Transfectlon Restrains Oral Cancer/nrasion by Reducing Matrix Metalloproteinase Activities" American Journal of Pathology. 150・6. 2125-2132 (1997)
Hida, K., Shindoh, M. 等:“Antisenes E1AF 转染通过减少基质金属蛋白酶活性抑制口腔癌/治疗”美国病理学杂志 150・6 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hida, k., Shindoh, M. et al.: "Antisense EIAF transfectioin restrains cral cancer cell in vasion by reducing MMPs acttrities." Am. J. Pathol.151 (in press). (1997)
Hida, k.、Shindoh, M. 等人:“反义 EIAF 转染通过减少 MMP 活性来抑制结肠癌细胞的侵袭。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 11 条
    Development of gene delivery system using nanocoloid and its application for gene targeting therapy
    • 批准号:
      18390531
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.76万
    • 财政年份:
      2006
    • 负责人:
      SHINDOH Masanobu
    • 依托单位:
    Gene targeting therapy for oral carcinoma using adrenomedullin antagonisit.
    • 批准号:
      16390575
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.28万
    • 财政年份:
      2004
    • 负责人:
      SHINDOH Masanobu
    • 依托单位:
    Research on factors involved in prognosis of oral carcinoma.
    • 批准号:
      14370654
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.6万
    • 财政年份:
      2002
    • 负责人:
      SHINDOH Masanobu
    • 依托单位:
    Gene therapy for oral squamous cell carcinoma targeting tumor specific promoter activation
    • 批准号:
      12671834
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2000
    • 负责人:
      SHINDOH Masanobu
    • 依托单位:
    海外基金